Nutrex Research Lipo-6 Hers, Lipo-6 Black and Ignite Purchasers File Class Action Lawsuit Complaint Against Nutrex Research In New Jersey State Court
A class action lawsuit complaint was filed against Nutrex Research, Inc. and certain individuals (collectively “Defendants”) in the Superior Court of New Jersey, Passaic County (captioned Christina Collucci and Scott Mahoney v. Nutrex Research, Inc. et al., Case No. L291310) alleging that Nutrex Research markets and sells its dietary supplements Lipo-6 Hers, Lipo-6 Black and Ignite as “all natural” even though the sports nutritional supplements purportedly contain methylsynephrine, allegedly another name for prescription drug Oxilofrine or PMMA, a performance enhancing drug PED or amphetamine banned by the U.S. and World Anti-Doping Agencies, according to class action lawsuit news reports.
The Nutrex Research Lipo-6 Hers, Lipo-6 Black and Ignite class action lawsuit complaint is reportedly brought on behalf of a putative class of all persons residing in the State of New Jersey who purchased the Lipo-6 Hers, Lipo-6 Black and Ignite dietary supplement for personal use and not for reseal during June 10, 2004 through the present and who are not otherwise excluded from the proposed class action definition.
For more information on the Nutrex Research Lipo-6 Hers, Lipo-6 Black and Ignite class action lawsuit, read the Nutrex Research Lipo-6 Hers, Lipo-6 Black and Ignitte class action lawsuit complaint.
If You Have Thoughts On The Nutrex Research Lipo-6 Hers, Lipo-6 Black and IgniteClass Action Lawsuit, Share Your Class Action Comments Below.